Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2013 50.00%
June 30, 2013 55.56%
March 31, 2013 57.14%
December 31, 2012 48.39%
September 30, 2012 60.00%
June 30, 2012 51.72%
March 31, 2012 64.71%
December 31, 2011 64.71%
September 30, 2011 60.00%
June 30, 2011 66.06%
March 31, 2011 82.05%
December 31, 2010 0.00%
September 30, 2010 81.82%
June 30, 2010 76.87%
March 31, 2010 79.39%
December 31, 2009 14.81%
September 30, 2009 35.87%
June 30, 2009 53.33%
March 31, 2009 72.86%
December 31, 2008 20.69%
September 30, 2008 22.73%
June 30, 2008 -32.73%
March 31, 2008 -54.17%
December 31, 2007 -7.32%
September 30, 2007 -144.4%
Date Value
June 30, 2007 40.00%
March 31, 2007 13.33%
December 31, 2006 38.75%
September 30, 2006 0.00%
June 30, 2006
March 31, 2006
December 31, 2005
September 30, 2005
June 30, 2005
March 31, 2005
December 31, 2004
September 30, 2004 0.00%
June 30, 2004 0.00%
March 31, 2004 -125.0%
December 31, 2003 -41.67%
September 30, 2003 0.00%
June 30, 2003 0.00%
March 31, 2003
December 31, 2002
September 30, 2002
June 30, 2002
March 31, 2002 83.33%
December 31, 2001
September 30, 2001 88.89%
June 30, 2001 88.89%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
LadRx Corp. --
Yield10 Bioscience, Inc. --
Longport, Inc. --
Genocea Biosciences, Inc. --
GlobeImmune, Inc. --